U.S. CDC panel to discuss COVID-19 shots for younger kids on Nov. 2

This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEH9Q1AD_L.jpg

Advisors to the U.S. Food and Drug Administration had on Tuesday voted overwhelmingly to recommend that the regulator authorize Pfizer (NYSE:PFE) and BioNTech’s vaccine for younger children.

The shot has been authorized for ages 12-15 since May and it was cleared for those aged 16 and above in December last year.